meta
|
evidence
oncology
Living systematic review and meta-analysis
metastatic/advanced OC (mOC) - maintenance (M)
1
pancreatic ductal adenocarcinoma
PIK3CA-related overgrowth spectrum
prostate cancer (PC)
immune chekpoint inhibitors
anti-PD-(L)1
avelumab based treatment
avelumab plus SoC
versus all
vs chemotherapy
vs Standard of Care (SoC)
All patients
Top evidence (RCT only, high risk of bias excluded)
Best available evidence (possibly low or very low)
All RCTs
All studies (RCT+OBS)
study list
mapping
overview
meta-analysis
forest plot
NMA
excluded
button
bars
forest
bayes
pooled
summary
circles
Statistically conclusive or suggested result
Inconclusive results
Uncertain results
Safety results
metastatic/advanced OC (mOC) - maintenance (M)
metastatic/advanced OC (mOC) - maintenance (M)
×
delta: difference in rate or median (if available)
×
Extraction panel open
An extraction panel is open